This genetic insight, combined with biomarker tracking (albumin, micronutrients, metabolic markers), enables truly personalized nutrition protocols rather than population-average recommendations
Each pen provides 4 weekly doses
When switching makes clinical sense (and when it doesn't) Strong clinical rationale for switching from Wegovy to Zepbound: Inadequate weight loss after 6+ months at Wegovy 2.4 mg
Insights from the Study The study, led by David Liss, a research associate professor at Northwestern University Feinberg School of Medicine, uncovered an alarming pattern within the GLP-1 RA Medications class
Many clients report a noticeable energy lift within 2448 hours of a B12 shot
It can be difficult to tell the difference between expected appetite changes and concerning behaviors with GLP-1 use